[Sponsored] FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease. The post Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options appeared first on MedCity News.
CHARLOTTE, N.C. — Purple flags, representing the nearly 300 Mecklenburg County residents who died of opioid overdose in 2023, fluttered in the humid breeze last August in recognition of International Overdose Awareness Day on the city’s predominantly Black west side. As recently as five years ago, the event might have attracted an overwhelmingly white crowd….
It’s a holy grail of health care: forcing the industry to reveal prices negotiated between health plans and hospitals — information that had long been treated as a trade secret. And among the flurry of executive orders President Donald Trump signed during his first five weeks back in office was a promise to “Make America…
By VINCE KURAITIS, GIRISH MURALIDHARAN & JODY RANCK This entry is Section 2 of part 3 of 3 in the series Platforming Healthcare — The Long View. This essay is the next in the series entitled “Platforming Healthcare — the Long View”. The series presents a 30-Year Framework for Platforming Healthcare. An updated v2.0 of…
Healthcare Economist was once again named one of the Top 10 Health Economics Blogs and Websites in 2025 (#4) by Feedspot. Feedspot also named this blog as a top 50 Best Public Health Blogs and Websites in 2025 (#13). Exciting to keep the blogging going into the future!
That is the title of a new FTI Consulting white paper co-authored with Kyi-Sin Than. The abstract is below. In October 2023, ICER released a special assessment aimed at influencing CMS drug price negotiations for two direct-acting oral anticoagulants (DOACs) selected in the first round of Inflation Reduction Act (IRA) price negotiations in 2024: Eliquis®…
A new partnership between TeamHealth and Array Behavioral Care aims to enhance mental health support in emergency departments. The post TeamHealth, Array Behavioral Care Partner to Advance Emergency Behavioral Health Treatment appeared first on MedCity News.
Isomorphic Labs’ financing led the way for first quarter 2025 financings, but it comes amid headwinds for the biotech sector. Biotech financing activity has been slowing down, analysts say. The post An AI Biotech Hauls In $600M, Plus More Funding Highlights to Close 1Q 2025 appeared first on MedCity News.
All healthcare entities storing or transferring patient health information needs to be aware of a proposed update to HIPAA tackling data encryption. Bryan Marlatt, chief regional officer at CyXcel The post Pivot: Discussing the Impact of a Proposed HIPAA Security Update appeared first on MedCity News.
A KFF survey of state Medicaid officials examines state Medicaid and CHIP eligibility, enrollment, and renewal policies in place as of January 2025 as states return to routine operations following the unwinding of the continuous enrollment provision. The survey finds that states have broadly adopted policy and system changes to automate and improve the accuracy…